Literature DB >> 22021458

Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease.

Debra K Moser1, Sharon McKinley, Barbara Riegel, Lynn V Doering, Hendrika Meischke, Michele Pelter, Patricia Davidson, Heather Baker, Kathleen Dracup.   

Abstract

OBJECTIVE: To examine the association of symptoms of persistent anxiety with the development of acute cardiac events in patients with coronary heart disease (CHD) followed for 2 years. The prevalence of symptoms of anxiety is high in patients with CHD, but their effect on cardiac events and mortality has not been well characterized.
METHODS: Of 3522 patients with confirmed CHD enrolled, data on symptoms of anxiety were available at two time points in 3048 patients who were then followed up for detection of the composite end point of hospitalization for myocardial infarction, unstable or stable angina, other cardiac causes, or all-cause mortality. A composite anxiety symptoms score composed of baseline and 3-month anxiety data, in which the continuous-level scores were used, was tested using Cox proportional hazards regression model. Groups (persistent anxiety [anxiety at both time points] versus nonanxious [no anxiety at either time point] versus not persistently anxious [anxiety only at one time point]) were also compared.
RESULTS: Symptoms of persistent anxiety, whether considered as a continuous- or categorical-level variable, were associated with shorter time to event. Persistent anxiety remained as an independent predictor of the end point after controlling for multiple variables (persistent anxiety as a summary score [hazard ratio = 1.27, 95% confidence interval = 1.067-1.514] and persistent anxiety as a categorical variable [hazard ratio = 1.52, 95% confidence interval = 1.149-2.015]).
CONCLUSIONS: By measuring anxiety symptoms at more than one time point and controlling for relevant sociodemographic, comorbidity, risk factor, and psychological covariates, we illustrate that symptoms of persistent anxiety are a strong, independent predictor of cardiac event-free survival.

Entities:  

Mesh:

Year:  2011        PMID: 22021458     DOI: 10.1097/PSY.0b013e3182364992

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  17 in total

Review 1.  Selected psychological comorbidities in coronary heart disease: Challenges and grand opportunities.

Authors:  Karina W Davidson; Carmela Alcántara; Gregory E Miller
Journal:  Am Psychol       Date:  2018-11

2.  Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Julia M Farquhar; Gregory L Stonerock; James A Blumenthal
Journal:  Psychosomatics       Date:  2018-03-27       Impact factor: 2.386

Review 3.  Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.

Authors:  Eileen M Handberg; Jo-Ann Eastwood; Wafia Eteiba; B Delia Johnson; David S Krantz; Diane V Thompson; Viola Vaccarino; Vera Bittner; George Sopko; Carl J Pepine; Noel Bairey Merz; Thomas R Rutledge
Journal:  Womens Health (Lond)       Date:  2013-09

4.  Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Thomas Rutledge; Tanya S Kenkre; Vera Bittner; David S Krantz; Diane V Thompson; Sarah E Linke; Jo-Ann Eastwood; Wafia Eteiba; Carol E Cornell; Viola Vaccarino; Carl J Pepine; B Delia Johnson; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2013-02-12       Impact factor: 4.164

Review 5.  Exercise as Treatment for Anxiety: Systematic Review and Analysis.

Authors:  Gregory L Stonerock; Benson M Hoffman; Patrick J Smith; James A Blumenthal
Journal:  Ann Behav Med       Date:  2015-08

6.  Prevalence and implications of severe anxiety in a prospective cohort of acute chest pain patients.

Authors:  Julio Schwarz; Adesh Prashad; David E Winchester
Journal:  Crit Pathw Cardiol       Date:  2015-03

7.  Moderation of the effects of discrimination-induced affective responses on health outcomes.

Authors:  Meg Gerrard; Frederick X Gibbons; Mary E Fleischli; Carolyn E Cutrona; Michelle L Stock
Journal:  Psychol Health       Date:  2017-04-23

8.  White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis.

Authors:  Kelly R Bijanki; Ashley N Stillman; Stephan Arndt; Vincent A Magnotta; Jess G Fiedorowicz; William G Haynes; Joy T Matsui; Hans J Johnson; David J Moser
Journal:  Int J Geriatr Psychiatry       Date:  2013-01-24       Impact factor: 3.485

Review 9.  Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis.

Authors:  Christopher M Celano; Rachel A Millstein; C Andres Bedoya; Brian C Healy; Annelieke M Roest; Jeff C Huffman
Journal:  Am Heart J       Date:  2015-09-21       Impact factor: 4.749

10.  Patient-reported outcomes, sociodemographic and clinical factors are associated with 1-year mortality in patients with ischemic heart disease-findings from the DenHeart cohort study.

Authors:  Trine Bernholdt Rasmussen; Britt Borregaard; Pernille Palm; Rikke Elmose Mols; Anne Vinggaard Christensen; Knud Juel; Ola Ekholm; Charlotte Brun Thorup; Lars Thrysoee; Marie Gjengedal; Selina Kikkenborg Berg
Journal:  Qual Life Res       Date:  2021-07-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.